FDA
- Marketing authorisation holder: NOVARTIS
- Status: approved
🇺🇸 Lysipressin in United States
Lysipressin (LYPRESSIN) regulatory status in United States.
Marketing authorisations
FDA
- Application: NDA016755
- Marketing authorisation holder: NOVARTIS
- Local brand name: DIAPID
- Indication: SOLUTION — NASAL
- Status: approved
Lysipressin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Lysipressin approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Lysipressin in United States?
NOVARTIS holds the US marketing authorisation.